Compare SNPS & MMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNPS | MMM |
|---|---|---|
| Founded | 1986 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0B | 81.8B |
| IPO Year | 1992 | N/A |
| Metric | SNPS | MMM |
|---|---|---|
| Price | $526.15 | $165.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 9 |
| Target Price | ★ $566.13 | $173.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.3M |
| Earning Date | 02-25-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.05 | 6.26 |
| Revenue | $7,054,178,000.00 | ★ $24,825,000,000.00 |
| Revenue This Year | $39.24 | N/A |
| Revenue Next Year | $10.82 | $3.27 |
| P/E Ratio | $63.94 | ★ $26.39 |
| Revenue Growth | ★ 15.12 | 1.05 |
| 52 Week Low | $365.74 | $121.98 |
| 52 Week High | $651.73 | $174.69 |
| Indicator | SNPS | MMM |
|---|---|---|
| Relative Strength Index (RSI) | 73.32 | 53.53 |
| Support Level | $469.07 | $161.05 |
| Resistance Level | $524.98 | $166.53 |
| Average True Range (ATR) | 12.45 | 2.72 |
| MACD | 4.14 | 0.51 |
| Stochastic Oscillator | 94.81 | 86.01 |
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.